home / stock / elym / elym news


ELYM News and Press, Eliem Therapeutics Inc From 04/11/24

Stock Information

Company Name: Eliem Therapeutics Inc
Stock Symbol: ELYM
Market: NASDAQ
Website: eliemtx.com

Menu

ELYM ELYM Quote ELYM Short ELYM News ELYM Articles ELYM Message Board
Get ELYM Alerts

News, Short Squeeze, Breakout and More Instantly...

ELYM - Enlivex Therapeutics, Nyxoah SA, China SXT Pharmaceuticals among healthcare movers

2024-04-11 10:04:28 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Well...

ELYM - US Companies Moving the Markets, Morning edition
Thu, Apr 11, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 11.3% to $0.2025 on volume of 40,515,259 shares Rallybio Corporation (RLYB) rose 80.4% to $2.9401 on volume of 39,492,767 shares Trio Petroleum Corp. (TPET) rose 36.3% to $0.2499 on volume of 3...

ELYM - Eliem Therapeutics Enters $120 Million Private Placement to Acquire Tenet Medicines

2024-04-11 08:24:49 ET DENVER, Colo., Apr 11, 2024 ( 247marketnews.com )- Eliem Therapeutics (NASDAQ: ELYM ) and Tenet Medicines announced that the companies entered into an agreement in which Eliem is acquiring Tenet, to form a combined company that focuses on advancing TNT119, a p...

ELYM - Eliem Therapeutics to buy Tenet, announces $120 million private placement

2024-04-11 07:17:17 ET Read the full article on Seeking Alpha For further details see: Eliem Therapeutics to buy Tenet, announces $120 million private placement

ELYM - Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

Transaction to add clinical-stage program directed towards treating unmet needs in autoantibody-mediated diseases Combined company expected to have approximately $210 million of cash and cash equivalents, including $120 million from a concurrent private placement of common stock from le...

ELYM - ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023

2024-04-05 06:53:01 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Eliem Therapeutics (NASDAQ: ELYM ) just reported results for the fourth quarter of 2023. Eliem Therapeutics reported earnings per share of -13 cents. The company did n...

ELYM - Expected US Company Earnings on Monday, April 1st, 2024

GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...

ELYM - Expected US Company Earnings on Monday, March 25th, 2024

Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...

ELYM - Expected US Company Earnings on Monday, March 18th, 2024

Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...

ELYM - Expected US Company Earnings on Monday, March 11th, 2024

Volcon Inc. (VLCN) is expected to report for Q4 2023 Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31 Hesai Group (HSAI) is expected to report for Q4 2023 Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023 Eliem Therapeutics Inc (ELYM) i...

Previous 10 Next 10